NM_000507.4:c.841G>A

Variant summary

Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM1PM2PP3_StrongPP5_Very_Strong

The NM_000507.4(FBP1):​c.841G>A​(p.Glu281Lys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000415 in 1,614,142 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).

Frequency

Genomes: 𝑓 0.000013 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000044 ( 0 hom. )

Consequence

FBP1
NM_000507.4 missense

Scores

14
4
1

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:13

Conservation

PhyloP100: 7.73
Variant links:
Genes affected
FBP1 (HGNC:3606): (fructose-bisphosphatase 1) Fructose-1,6-bisphosphatase 1, a gluconeogenesis regulatory enzyme, catalyzes the hydrolysis of fructose 1,6-bisphosphate to fructose 6-phosphate and inorganic phosphate. Fructose-1,6-diphosphatase deficiency is associated with hypoglycemia and metabolic acidosis. [provided by RefSeq, Jul 2008]
PCAT7 (HGNC:48824): (prostate cancer associated transcript 7)

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 16 ACMG points.

PM1
In a binding_site (size 0) in uniprot entity F16P1_HUMAN
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.961
PP5
Variant 9-94603557-C-T is Pathogenic according to our data. Variant chr9-94603557-C-T is described in ClinVar as [Likely_pathogenic]. Clinvar id is 381580.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FBP1NM_000507.4 linkc.841G>A p.Glu281Lys missense_variant Exon 7 of 7 ENST00000375326.9 NP_000498.2 P09467
FBP1NM_001127628.2 linkc.841G>A p.Glu281Lys missense_variant Exon 8 of 8 NP_001121100.1 P09467Q2TU34
FBP1XM_006717005.5 linkc.595G>A p.Glu199Lys missense_variant Exon 7 of 7 XP_006717068.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FBP1ENST00000375326.9 linkc.841G>A p.Glu281Lys missense_variant Exon 7 of 7 1 NM_000507.4 ENSP00000364475.5 P09467

Frequencies

GnomAD3 genomes
AF:
0.0000131
AC:
2
AN:
152172
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000756
AC:
19
AN:
251476
Hom.:
0
AF XY:
0.000118
AC XY:
16
AN XY:
135920
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000544
Gnomad SAS exome
AF:
0.000588
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000445
AC:
65
AN:
1461852
Hom.:
0
Cov.:
34
AF XY:
0.0000715
AC XY:
52
AN XY:
727234
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0000252
Gnomad4 SAS exome
AF:
0.000684
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000180
Gnomad4 OTH exome
AF:
0.0000331
GnomAD4 genome
AF:
0.0000131
AC:
2
AN:
152290
Hom.:
0
Cov.:
32
AF XY:
0.00
AC XY:
0
AN XY:
74472
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000415
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000993
Hom.:
0
Bravo
AF:
0.00000378
ExAC
AF:
0.0000741
AC:
9

ClinVar

Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:13
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Fructose-biphosphatase deficiency Pathogenic:12
Jun 17, 2024
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Variant summary: FBP1 c.841G>A (p.Glu281Lys) results in a conservative amino acid change located in the fructose-1-6-bisphosphatase class 1, C-terminal domain (IPR044015) of the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 7.6e-05 in 251476 control chromosomes. This frequency is not significantly higher than estimated for a pathogenic variant in FBP1 causing Fructose-biphosphatase deficiency, allowing no conclusion about variant significance. c.841G>A has been reported in the literature in the compound heterozygous and homozygous states in multiple individuals affected with Fructose-biphosphatase deficiency (e.g. Afroze_2013, Kato_2015, Bhai_2018). These data indicate that the variant is very likely to be associated with disease. At least one in vitro study in HepG2 cells reports experimental evidence that this variant results in significantly reduced enzyme activity compared to wildtype. The following publications have been ascertained in the context of this evaluation (PMID: 23881342, 29774539, 26549536, 37507476). ClinVar contains an entry for this variant (Variation ID: 381580). Based on the evidence outlined above, the variant was classified as pathogenic. -

-
Kasturba Medical College, Manipal, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, India
Significance: Likely pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

May 22, 2022
3billion
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The variant is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: 0.008%). In silico tool predictions suggest damaging effect of the variant on gene or gene product (REVEL: 0.82; 3Cnet: 0.97). Same nucleotide change resulting in same amino acid change has been previously reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000381580). The variant has been observed in multiple (>3) similarly affected unrelated individuals (PMID:23881342, 27101822, 29016355, 29774539). Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline. -

-
Centogene AG - the Rare Disease Company
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jul 10, 2012
Institute of Medical Genetics and Genomics, Sir Ganga Ram Hospital
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Apr 09, 2021
Revvity Omics, Revvity
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Mar 06, 2022
Baylor Genetics
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Apr 19, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 281 of the FBP1 protein (p.Glu281Lys). This variant is present in population databases (rs566453434, gnomAD 0.06%). This missense change has been observed in individuals with fructose-1,6-bisphosphatase deficiency (PMID: 23881342, 27101822, 29016355, 29774539; Invitae). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 381580). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt FBP1 protein function with a positive predictive value of 80%. For these reasons, this variant has been classified as Pathogenic. -

-
Lifecell International Pvt. Ltd
Significance: Likely pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

A Heterozygous Missense variant c.841G>A in Exon 7 of the FBP1 gene that results in the amino acid substitution p.Glu281Lys was identified. The observed variant has a minor allele frequency of 0.00008% in gnomAD exomes and genomes, respectively. The severity of the impact of this variant on the protein is high, based on the effect of the protein and REVEL score. Rare Exome Variant Ensemble Learner (REVEL) is an ensembl method for predicting the pathogenicity of missense variants based on a combination of scores from 13 individual tools: MutPred, FATHMM v2.3, VEST 3.0, PolyPhen-2, SIFT, PROVEAN, MutationAssessor, MutationTaster, LRT, GERP++, SiPhy, phyloP, and phastCons. The REVEL score for an individual missense variant can range from 0 to 1, with higher scores reflecting greater likelihood that the variant is disease-causing. ClinVar has also classified this variant as Pathogenic/ Likely Pathogenic with 2 stars, criteria provided, multiple submitters, no conflicts (Variant ID: 381580). This variant has previously been reported for fructose-1,6-bisphosphatase deficiency by Santer R,et,al.,2016. Based on the above evidence this variant has been classified as Likely Pathogenic according to the ACMG guidelines. -

Jun 19, 2024
Fulgent Genetics, Fulgent Genetics
Significance: Likely pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Oct 11, 2020
Biochemical Molecular Genetic Laboratory, King Abdulaziz Medical City
Significance: Likely pathogenic
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Dec 21, 2022
Center for Molecular Medicine, Children’s Hospital of Fudan University
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not provided Pathogenic:1
Jul 04, 2023
GeneDx
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 27101822, 29774539, 29016355, 31584309, 23881342, 33083013, 26549536) -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.99
BayesDel_addAF
Pathogenic
0.19
D
BayesDel_noAF
Pathogenic
0.39
CADD
Pathogenic
32
DANN
Pathogenic
1.0
DEOGEN2
Uncertain
0.69
.;D;D
Eigen
Pathogenic
0.90
Eigen_PC
Pathogenic
0.75
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Pathogenic
1.0
D;.;D
M_CAP
Pathogenic
0.58
D
MetaRNN
Pathogenic
0.96
D;D;D
MetaSVM
Pathogenic
0.86
D
MutationAssessor
Pathogenic
4.0
.;H;H
PrimateAI
Uncertain
0.68
T
PROVEAN
Uncertain
-3.6
.;D;D
REVEL
Pathogenic
0.82
Sift
Pathogenic
0.0
.;D;D
Sift4G
Pathogenic
0.0
.;D;D
Polyphen
1.0
.;D;D
Vest4
0.90
MutPred
0.90
.;Gain of methylation at E281 (P = 0.0036);Gain of methylation at E281 (P = 0.0036);
MVP
0.95
MPC
1.1
ClinPred
0.97
D
GERP RS
5.4
Varity_R
0.94
gMVP
0.92

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs566453434; hg19: chr9-97365839; API